Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

Table 1

Biochemical, anthropometric, and clinical characteristics of the Parkinson disease (PD) patient population enrolled, 𝑛=30, 𝑀/𝐹=19(64%)/11(36%). Data are expressed as mean ± SD.

Parameter	Data (mean ± standard deviation)
Age (years)	62.4 ± 10.63
Duration of disease (years)	8.7 ± 6.1
Levodopa (mg)	532.7 ± 220.1
BMI (Kg/m^2)	25.5 ± 4.2
Weight (Kg)	71.8 ± 15.7
Waist circumference (cm)	95.23 ± 15.8
Arm circumference (cm)	28.4 ± 3.97
Fat mass (%)	32.3 ± 7.74
Fat-free mass (%)	67.7 ± 6.7
Albumin (g/dL)	3.89 ± 0.2
Transferrin (mg/dL)	243.6 ± 40.5
Creatinine (mg/dL)	0.67 ± 0.1
ALT (U/L)	13.5 ± 6.6
AST (U/L)	16.8 ± 4.9
Triglycerides (mg/dL)	97.5 ± 46.3
Glucose (mg/dL)	87.5 ± 14.9
Total cholesterol (mg/dL)	189.0 ± 46.21
HDL cholesterol (mg/dL)	51.8 ± 16.4
Adiponectin (μg/mL)	9.59 ± 5.97